pa|Welcome to Sectra Group A very strong corporate culture based on the employees’ expertise and attitudes and their drive to solve customer problems is one of the reasons you should consider investing in Sectra. Explore five more good reasons.
di|Menu Looking for an exciting future career? French hospital specialized in neuroscience chooses Sectra’s digital pathology solution to improve diagnostics 2021-03-25 | Medical Systems Sectra helps civil authorities and large corporations protect their digital communication with a service that supplements existing products 2021-03-22 | Sectra’s nine-month interim report 2020/2021: Increased order bookings and the industry’s most satisfied customers for the eighth consecutive year 2021-03-12 | Financial Information
st|Driven by knowledge and passion, our vision is to contributeSectra successfully develops and sells cutting-edge solutions in the expanding niche segments of medical IT and cybersecurity—a combination that makes us unique.
h1|We contribute
h2|Enterprise imaging Secure communications & critical infrastructure Orthopaedics Medical education & clinical training Latest news Why invest in Sectra
h3|About Sectra Follow us

COVID-19: Information on how Sectra is addressing the situation Career at Sectra Show more
pa|You are here: Business operations are conducted at Sectra AB in two business areas: Medical Systems and. Business functions shared between the business areas—e.g. tools, quality, regulatory affairs and internal IT—reside in the department of Operational Excellence and IT. The quality management system conforms to the Quality Management System Standards SS-EN ISO 9001:2008, SS-EN ISO 13485:2003 and, for medical devices placed on the Canadian market, to ISO 13485:2003/CMDCAS. All medical devices meet the provisions of the Medical Devices Directive 93/42/EEC. All medical devices placed on the US market have obtained FDA market clearance. See also: The management system conforms with the Quality Management System Standard SS-EN ISO 9001:2008. The certificate is valid for “Sales, development, production, delivery and service of hardware and software products for secure communication systems”. All products and systems are designed according to ITSEC standard (Information Technology Security Evaluation Criteria). The information security management system conforms to the standard SS-ISO/IEC 27001:2013. Any product, service or technology described on this server may be subject of Intellectual Property Rights reserved by Sectra AB or any of its subsidiaries. © 1994 – 2021 Sectra AB, Sweden. All rights reserved. No parts of the Sectra website may be reproduced, in any form or by any means, without permission in writing from Sectra AB, Sweden. However, any person is hereby authorized to copy, print and distribute any document published by Sectra on the sectra.com website provided that: Information on this server is provided “as is” without any warranty of any kind, either express or implied, including but not limited to, the implied warranties of merchantability, fitness for a particular purpose, or non-infringement. The information herein may include technical inaccuracies or typographical errors. Changes may periodically be made to the information and will be incorporated in new editions. Sectra AB may make improvements or changes in products described at any time without notice. Contact information submitted to the Sectra website will be handled confidentially. All contact information will be used solely for the purposes outlined in the corresponding form. Please see the page for information about how this Sectra website uses cookies. If you have any questions, please feel free to contact Sectra at one of the addresses listed on the .
di|Menu
li|Sectra®, the Sectra Logo, the Sectra Circles and the Sectra “Your Partner in PACS” handshake are registered trademarks of Sectra AB. Sectra Imtec®, Imtec®, ImageServer®, WARDline®, Pronosco® and Pronosco X-posure System® are registered trademarks of Sectra AB. FIMAG and Image Exchange Portal are registered trademarks of Burnbank Systems Ltd in the UK. RxEye is a registered trademark of RxEye AB. Your Partner in PACS™, Sectra IDS7™, Sectra IDS5™, Sectra IDS5/dx™, Sectra IDS5/tech™, IDS5/qa™, Sectra IDS5/clinic™, IDS5/cl™, IDS5/clinic.net™, IDS5/cl.net™, Sectra IDS5/home,™ Sectra IDS5/send™, Sectra IDS4™, Sectra WISE™, Sectra WISE/web™, Sectra WISE/tools™, Sectra WISE/watch™, Sectra WISE/lock™, Sectra WISE/doc™, Sectra WISE/lite™, Sectra LaserServer™, Sectra SMIIC-v™, Sectra SMIIC-s™, Sectra PACS Enterprise Edition™, Sectra PACS Clinical Edition™, Sectra ModularPACS™, Sectra LitePACS™, Clinical Solutions Network™, Sectra Medical Interfaces™, Clinical Application Interface™, Sectra Medical API™, Cross-Platform Worklist™, Sectra BizTrack™, Sectra OpenArchive™, Sectra VNA™, Sectra DoseTrack™, Sectra OneScreen™ and PreopOnline™ are trademarks of Sectra AB. Conrad™, Kundrad™, Mamrad™ and Rondrad™ are trademarks of Sectra Sverige AB. Tiger®,Panthon® and Ternety® are registered trademarks of Sectra Communications AB. LinkedIn, the LinkedIn logo, the IN logo and InMail are registered trademarks or trademarks of LinkedIn Corporation and its affiliates in the United States and/or other countries. Facebook, the Facebook logo and F logo are registered trademarks of Facebook Inc. Google, the Google logo, Google Analytics, Google Chrome, Gmail, the g+ and g+1 logos, YouTube and the YouTube logo are registered trademarks or trademarks of Google Inc. Yahoo!, Flickr and the Flickr logo are registered trademarks of Yahoo! Acrobat, the Acrobat logo, Postscript, Shockwave and Flash are trademarks or registered trademarks of Adobe Systems Incorporated. ActiveX, BizTalk, DirectX, Hotmail, Internet Explorer and the Internet Explorer logo, MSN, the .Net logo, Outlook, Skype, the Skype logo, Windows, Windows Live, Windows Server and Windows Vista are registered trademarks of Microsoft Corporation. iPad, iPhone, Safari and QuickTime are registered trademarks of Apple Inc. UNIX is a trademark registered in the United States and other countries, licensed exclusively through X/Open Company, Ltd. All other trademarks and registered trademarks are property of their respective holders. a reference to sectra.com is made when the document is used the document is used for information purposes only the document is used for non-commercial purposes only
h1|Legal information
h2|About the Sectra Corporation Compliance with regulations Trademarks The Sectra website Disclaimer Privacy Contact Sectra
h3|Medical Systems Operational Excellence and IT Other trademarks About Sectra Follow us

/ Legal information
pa|Sectra Group You are here: Information last updated: February 5, 2021 The COVID-19 situation is causing increased uncertainty around the world. Given Sectra’s critical role in ensuring functioning health care and infrastructure, customer support and service are our top priorities. In addition, we must ensure the health and safety of our employees. Sectra is continuously reviewing the situation, adapting our operations to avoid disruptions and finding ways to add value for our customers during these turbulent times. We can also see that our systems are helping to deliver the care needed under these extraordinary circumstances. Examples of this include our remote education systems and remote reading for doctors who are working from home. Furthermore, we are supporting our customers in all sectors to securely communicate sensitive information, even when people are working from home. Below you find answers to frequently asked questions (FAQ) from customers, shareholders, employees and other stakeholders. As we are a provider of medical imaging IT solutions for healthcare as well as cybersecurity services for government agencies and critical infrastructure, we have a decisive role to play in keeping our solutions, services and support available to our customers. They depend on our systems to function flawlessly so that they in turn can provide their services in this challenging situation. Accordingly, our number one priority is keeping our systems operational. Customer support and services are key and, if needed, every single Sectra employee may be required to provide assistance to ensure that these functions operate as intended, regardless of their normal job. We are in close contact with customers to ensure we are well-prepared to address their needs so that they can concentrate on helping their patients and safeguarding society. We are taking the necessary steps to make sure we can continue assisting our customers, add value and protect the health and safety of our employees. These steps include: Our business continuity plans are in effect to support our systems, enabling our customers to focus on patient care and cybersecurity while also endeavoring to slow the spread of the coronavirus. Secure remote support will remain unchanged for the foreseeable future. We have the infrastructure in place to run 100% of our support remotely. Even if Sectra offices were to be quarantined, this would not impact our service delivery model. Support and service teams work remotely to reduce the risk of infection and to comply with restrictions from government authorities. When Sectra secures a contract, meeting our established timelines and honoring our commitments is of the utmost importance for the company. Go-lives are planned months in advance and involve multiple staff members. We will continue deliveries according to existing deployment schedules where possible. We are continuously evaluating and developing our way of working and some of the ongoing deployments are being implemented remotely. That said, for many hospitals, preparing and installing, or acquiring, new IT systems is not a priority at this time. This may, in some instances and in some regions, lead to delivery delays due to customer demands or limitations. We have implemented restrictions and recommendations for our employees. These include: In many Sectra offices around the world, a large portion of staff are now working from home. Our observations are that this is working well. It is vital to avail of digital tools, such as Microsoft Teams or equivalent software, to maintain a coordinated approach in projects and work groups. Regular meetings are thus held several times a day in work group or projects. More than half of Sectra’s invoicing comprises recurring revenue, and as communicated in our financial reports, we see no reason to believe that this portion of the Group’s revenue would be affected more than marginally even if the situation were to worsen. As per fiscal year 2019/2020, Sectra’s geographic markets as a share of Group net sales are as follows: Sectra has a strong balance sheet with a positive net cash funds and a high level of creditworthiness. As of April 30, 2020, cash and cash equivalents and unutilized credit facilities totaled SEK 360.3 million and interest-bearing liabilities in the form of convertible debt instruments totaled SEK 6.5 million. Sectra routinely monitors the cash flow from operations, investments and financing to ensure that the Group has sufficient funds available to meet future anticipated and potential demands. For quarterly updates of our financial figures, see . The pandemic has promoted greater uncertainty than normal, which means that predicting what effects COVID-19 will have on Sectra’s financial performance going forward is more difficult than usual for management and the Board. Sectra are not unaffected, but we are well equipped to handle the situation with a strong balance sheet, positive cash funds and significant recurring revenue. Sectra has neither needed nor received any support related to COVID-19 such as reduced rent or business transition support. No need for impairment is deemed to exist owing to the pandemic. In our Annual report and Sustainability report 2019/2020 we provide an update on risks related to the outbreak. Potential consequences for Sectra that could impact future financial outcomes include, but are not limited to: Refer to information on page 67 of the . For quarterly updates, see . For the country operations that have additional information on how the situation is handled locally, you can find it below.
di|Menu What prioritizations are Sectra making due to the coronavirus pandemic? How does Sectra continue to deliver high-quality customer support and services? How is Sectra handling deliveries, deployments and sales? What is Sectra doing to safeguard employee health and safety? What is the share of recurring revenue for Sectra and which countries are the most significant in terms of sales? What is Sectra’s liquidity position? What financial impact is the COVID-19 outbreak expected to have on Sectra?
li|Keep our solutions, services and support available to customers so they can ensure functional health and medical care as well as infrastructure. Safeguard the health of employees (and their families), customers and visitors to Sectra’s offices. Act calmly, preserve stability and keep a high standard in contingency planning. Maintain cybersecurity internally and among our customers. Ensure that customers, employees and other stakeholders understand how we are handling the situation and what measures we are taking. Continually evaluate and develop our approach to working remotely, both internally and with customers. Continually monitor and review the situation in order to adapt operations and avoid disruptions. First and foremost, we must follow local regulations. This means that Sectra’s handling of the situation will differ depending on the country or state If not enforced by law, we encourage employees to work from home, if possible Replacing face-to-face meetings with phone/online meetings when possible Restrictions to eliminate non-essential travel USA 28% Sweden 23% United Kingdom 14% Netherlands 9% Rest of Europe 20% Rest of the world 6% Delays in installation projects. Temporary pauses in procurements. Temporarily decreased demand for Sectra’s products. Significant variations between quarters as regards order bookings, earnings and cash flow.
h1|COVID-19: Information on how Sectra is addressing the situation
h2|FAQ Country-specific information
h3|Medical imaging IT About Sectra Follow us

/ Information on the COVID-19 situation ANZ Benelux Canada DACH Denmark France Norway Portugal Spain Sweden UK and Ireland USA Contact Sectra Group
pa|You are here: Sectra recognizes and respects the importance of privacy for visitors to our websites. This policy provides an account of the cookies used on our websites and the personal data we collect. Although Sectra does not automatically receive and store information from your web browser, such as IP address, cookie information and the pages you visit, Sectra may collect such personal data as your name, email address and other information that you voluntarily provide when filling out our forms or accepting cookies. You can control how we use cookies on your device by changing those settings at any time . A cookie is a small text file that is stored on your computer and used to recognize your computer upon return. The cookie may transmit information via your browser for the purpose of authenticating or identifying the computer (via the IP address, for example) or the user. Cookies may contain information such as registration data and user preferences. When a server receives a request from a computer that has stored a cookie from a website, the server can use the information stored in the cookie in combination with the information stored on the server. A cookie cannot collect information from your computer, nor can it contain viruses or other damaging files. There are similar methods for collecting data, such as LocalStorage and SessionStorage. These terms are used synonymously in this text. Cookies come in two types: persistent cookies and session cookies. Sectra’s website uses both types of cookies. A persistent cookie remains on a computer for a specified length of time, whereas a session cookie is stored temporarily in the computer’s memory for the duration of a site visit and disappears when you close the browser. You may delete cookies if you no longer wish to store them on your computer. Please refer to your browser’s help guide for further guidance. You can also easily control how we use cookies on your device by changing those settings at any time . Necessary cookies help make a website usable by enabling basic functions of the website. The website cannot function properly without these cookies. Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies are used to provide personalized services through other communication channels from Sectra. In addition, the website shows videos from YouTube, which will collect statistical information from visitors who watch the videos. You can control how we use cookies on your device by changing those settings at any time . Personal data (e.g. name, address, phone number, email address, IP address) and non-personal data (e.g. your operating system and browser) provided to Sectra AB through this website will be used only by companies within the Sectra Group, its subcontractors and service providers per the sections below. Sectra’s website may be used for purposes including, but not limited to, contact with Sectra, downloading white papers and subscription to article update newsletters. In conjunction with such purposes, we will ask you to enter the information (e.g. name, email, telephone number and other information) that is necessary for us to comply with your request and to initiate future contact regarding the same matter or other matters, if consent is provided. Sectra will only use your personal data to fulfill these relevant purposes. As a global company, Sectra may transfer personal data it has collected on an aggregate or individual level to various divisions, subsidiaries, and affiliated companies of the Sectra Group around the world located inside or outside the European Economic Area for the purposes stated above. We will delete or anonymize your personal data when it is no longer needed for the purposes for which it was collected and subsequently processed. If you have submitted personal data to us—when registering for article update newsletters, for example—you have the right to access and rectify your data. More details are provided below. This privacy and cookie policy was last updated on December 18, 2020. We reserve the right to amend and/or delete this privacy and cookie policy at any time, at our sole discretion, without providing prior notice to you. We will post the current version of this privacy and cookie policy on the website. Once per calendar year, you may at no cost obtain information regarding the personal data, relating to you as a data subject, that has been processed by Sectra. In addition, you always have the right to (i) request rectification of incorrect data, (ii) modify information that you have previously provided, (iii) revoke consent granted and state that you oppose further processing of your personal data or that you do not wish to continue receiving information from Sectra. If you revoke your consent, your personal data will be deleted as soon as possible. Sectra AB Teknikringen 20 SE-583 30 Linköping SWEDEN Phone: +46 13 23 52 00 Email: Sectra AB Teknikringen 20 SE-583 30 Linköping SWEDEN Phone: +46 13 23 52 00 Fax: +46 13 21 21 85 Email:
di|Menu
td|moove_gdpr_popup Sectra Handles user cookie settings in the cookie bar. It keeps record of your consent to store cookies. 365 days wordpress_test_cookie Sectra WordPress tests if cookies can be placed. Session cusid ClickDimensions Identifies if the user exists in our CRM. It is used to store website behavior to provide personalized services through other communication means from Sectra. Used for US IP addresses only. 30 minutes
st|Name Provider Purpose Duration Name Provider Purpose Expiry
h1|Privacy and cookie policy
h2|Cookies Personal data Changes Your right to extracts and correction of your personal data Contact information
h3|Necessary (2) Statistics (0) Marketing (1) Data protection officer Corporate headquarters About Sectra Follow us

/ Privacy and cookie policy
pa|You are here: Sectra is headquartered in Linköping, Sweden, and operates through own offices and partners worldwide. For inquires regarding investor and press relations, the Sectra group’s consolidated accounting, career at Sectra, etc., please see below. For product related inquiries, please see contact details for or , respectively. Sectra AB Teknikringen 20 SE-583 30 Linköping SWEDEN Phone: +46 13 23 52 00 Fax:+46 13 21 21 85 Email: Visit: If you decide to give us a call, our office hours at the Sectra Headquarters in Linköping are weekdays 8 a.m. to 6 p.m., UTC + 1. Email: Emma Järnkrok Press relations & Market communicator Direct: +46 13 23 53 18 Mobile: +46 70 483 97 40 Helena Pettersson Chief Investor & Press Relations Officer Direct: +46 13 23 52 04 Mobile: +46 706 27 52 04 Web: Helena Pettersson Chief Investor & Press Relations Officer Email: Direct: +46 13 23 52 04 Mobile: +46 706 27 52 04 Web: Email: Phone: +46 13 23 52 00 Email: Phone: +46 13 23 52 00 For any website issues, please contact
di|Menu
h1|Contact Sectra Group
h2|Sectra HQ Press contacts Investor contact Job contacts Data protection officer Webmaster
h3|About Sectra Follow us

/ Contact Sectra Group
pa|You are here: Linköping, Sweden and Paris, France – March 25, 2021 – GHU Paris psychiatrie & neurosciences has ordered a digital pathology solution from international medical imaging IT and cybersecurity company Sectra (http://www.sectra.com/) (STO: SECT B). The digital technology will maximize workflow efficiency and improve collaboration between pathologists, pushing the limits even further within the field of neuropathology. This will ultimately lead to more accurate and faster diagnoses for patients, which is key when deciding on a suitable treatment, especially in precision medicine. Linköping – March 22, 2021 – International cybersecurity and medical imaging IT company Sectra (https://sectra.com/) (STO: SECT B) is supplementing its offering of secure communication systems with a new service for secure digital communication and remote collaboration. The service will allow Swedish civil authorities and large corporations to communicate more efficiently without jeopardizing the security of their mobile communication between different platforms, such as iPhone, Android, Windows and Mac. The new service will enable voice communication and video conferencing with a high level of security. The servers for the service are located in the same country as the customer and therefore comply with national security requirements and rules regarding data processing and storage. Press release – Linköping, March 12, 2021 – International medical imaging IT and cybersecurity company Sectra (https://investor.sectra.com/) (STO: SECT B) has received a top ranking in customer satisfaction surveys in the category of diagnostic imaging systems for radiology in the US, Canada and Europe as well as in the category of digital pathology. As a result of having the market’s most satisfied customers for many years, demand for the company’s offerings is high and order bookings increased 79% compared with the year-earlier period. The third quarter of the preceding fiscal year was extremely strong and the results for this year did not quite reach the same level. The results were hampered by limited delivery opportunities in certain areas of the operations due to the COVID-19 pandemic and by a stronger SEK. Based on unadjusted exchange rates, sales for the nine-month period were on par with the year-earlier period. With tight restrictions still in place in several countries, the heightened risk of delivery delays is expected to continue in the coming quarter. However, Sectra is relatively well equipped to manage the pandemic based on a strong financial position, positive cash flows and a significant share of recurring revenue. Linköping, Sweden and Shelton, CT – March 11, 2021 – International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) will install its enterprise imaging solution at Atlanta-based, Emory Healthcare. The contract, signed in February, includes modules for radiology and all imaging subspecialties, orthopedics, and image archiving. Patient linking will be set up with sister institution, Grady Health System, to ensure physicians at both locations have access to shared patient images and reports. Linköping, Sweden – March 10, 2021 – The EU council has approved the latest version of the eavesdrop-proof mobile phone Sectra Tiger/S 7401 LTE from international cybersecurity and medical imaging IT company Sectra (https://sectra.com/) (STO: SECT B). This approval, which applies to the security level SECRET, certifies the latest Sectra Tiger/S version for sharing information that, if it fell into the wrong hands, could severely damage the security of the EU and its member nations. Linköping, Sweden – February 18, 2021 – International medical imaging IT and cybersecurity company Sectra (http://www.sectra.com/) (STO: SECT B) will publish its interim report for the May 2020-January 2021 period on March 12. Sectra invites analysts, investors, and the media to attend a teleconference/audiocast in conjunction with the publication of the report. Furthermore, the Board has approved the 2021/2022 financial reporting calendar and has set the date for the company’s Annual General Meeting, which will be held on September 14, 2021, in Linköping, Sweden. Linköping, Sweden – February 9, 2021 – Several EU institutions have procured additional units of the Sectra Tiger mobile encryption system from international cybersecurity and medical imaging IT company Sectra (https://sectra.com/) (STO: SECT B). The Sectra Tiger system will ensure that users are able to securely and efficiently communicate classified information up to and including the EU SECRET security level, with full availability anywhere and at any time. Linköping, Sweden – February 2, 2021 – International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) has won the prestigious customer satisfaction award ‘Best in KLAS’ for PACS for the eighth consecutive year. Sectra is ranked number one by healthcare providers in three regions: US (Large PACS and Small PACS), Canada, and Europe. The company has also swept the new award for Digital Pathology (non-US). The awards are given by the healthcare IT data and insights company KLAS Research. Nijmegen, 28 January 2021 - To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data. The 6-year, €70 million project called BIGPICTURE, will herald a new era in pathology. Linköping, Sweden – January 21, 2021 – International medical imaging IT and cybersecurity company Sectra (http://www.sectra.com/) (STO: SECT B) has received an order for its digital pathology solution from Amsterdam UMC in the Netherlands. This follows a recently announced radiology imaging contract (https://medical.sectra.com/news-press-releases/?item=D5AFDA07861CC966). With radiology and pathology in one joint solution, Amsterdam UMC will be able to conveniently share images and information between the two medical specialties, enabling efficient integrated diagnostics and improved patient-centric care. Linköping, Sweden – January 19, 2021 – International medical imaging IT and cybersecurity company Sectra (http://www.sectra.com/) (STO: SECT B) has received an order from Institut Bergonié for its digital pathology solution. It will be one of the first digital pathology installations for full-scale primary diagnostics in France. The solution will enable pathologists to review and collaborate around cases in a manner previously not possible using a microscope. It reduces variation and increases efficiency, thereby improving care for cancer patients. Linköping, Sweden – January 14, 2021 – The healthcare provider Region of Southern Denmark has gone live with a digital pathology solution from international medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B). The IT solution makes it possible for pathologists at the region’s four hospitals to review and collaborate around cases in a way that is not possible with microscopes. This supports increased efficiency in primary diagnostics, thereby improving cancer care. Linköping, Sweden – January 11, 2021 – The Pennine Acute Hospitals NHS Trust has become the first of eight NHS trusts in the UK to deploy the imaging IT solution from international medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B). This follows the announcement of the enterprise imaging contract in October 2020 (https://medical.sectra.com/news-press-releases/?item=CD318329A912983D). The go-live is transforming how clinical staff examine crucial patient images. Faster diagnoses for millions of people, new possibilities around AI, and region-wide collaboration are just some of the benefits that will follow.
di|Menu French hospital specialized in neuroscience chooses Sectra’s digital pathology solution to improve diagnostics 2021-03-25 | Medical Systems Sectra helps civil authorities and large corporations protect their digital communication with a service that supplements existing products 2021-03-22 | Sectra’s nine-month interim report 2020/2021: Increased order bookings and the industry’s most satisfied customers for the eighth consecutive year 2021-03-12 | Financial Information Sectra signs five-year enterprise imaging contract with Emory Healthcare in the US 2021-03-11 | Medical Systems Quantum-proof crypto from Sectra receives SECRET approval from EU 2021-03-10 | Invitation to presentation of Sectra’s nine-month interim report on March 12 and date for 2021 Annual General Meeting 2021-02-18 | Financial Information EU orders Sectra Tiger solution for sharing classified information 2021-02-09 | Sectra ranked #1 in customer satisfaction — earns 5 KLAS awards in PACS and digital pathology 2021-02-02 | Medical Systems A new consortium of the EU Innovative Medicines Initiative (IMI) will establish the biggest database of pathology images to accelerate the development of artificial intelligence in medicine Published: 2021-01-28 | Edited: 2021-01-29 | Medical Systems Amsterdam UMC adds digital pathology to its existing Sectra solution to enable integrated diagnostics for better cancer care 2021-01-21 | Medical Systems Institut Bergonié among the first in France to implement full-scale digital pathology—improves care for cancer patients with solution from Sectra 2021-01-19 | Medical Systems Healthcare region pioneering digital pathology reviews in Denmark with Sectra—aims to significantly shorten cancer turn-around times 2021-01-14 | Medical Systems Rapid go-live as first trust in Greater Manchester patient diagnostic imaging initiative deploys Sectra solution 2021-01-11 | Medical Systems
h1|News and press releases
h3|Latest news About Sectra Follow us

Subscribe / News and press releases Show more
pa|You are here:
di|Menu Mar 25, 2021 | Medical Systems | France
h1|French hospital specialized in neuroscience chooses Sectra’s digital pathology solution to improve diagnostics
h2|Images
h3|About Sectra Follow us

/ / French hospital specialized in neuroscience chooses Sectra’s digital pathology solution to improve diagnostics Linköping, Sweden and Paris, France – March 25, 2021 – GHU Paris psychiatrie & neurosciences has ordered a digital pathology solution from international medical imaging IT and cybersecurity company (STO: SECT B). The digital technology will maximize workflow efficiency and improve collaboration between pathologists, pushing the limits even further within the field of neuropathology. This will ultimately lead to more accurate and faster diagnoses for patients, which is key when deciding on a suitable treatment, especially in precision medicine. “As an expert center in neuropathology, we process a high volume of second readings from other centers, especially within rare tumors. Having access to image analysis tools is therefore a huge advantage for us. With Sectra, we now have these tools in hand, and because the solution is easy to use, our pathologists will be able to utilize the benefits from day one,” says Professor Pascale Varlet, pathologist at GHU Paris psychiatrie & neurosciences. Brain tissue samples analyzed by GHU Paris are either collected at their own site or received from other hospitals. By scanning tissue samples to digital images instead of using physical glass slides, pathologists can access and share current and historical images and information from anywhere at any time. Furthermore, Sectra’s solution provides pathologists with assistance at critical decision points, such as grading or performing more precise measurements. It also enables image analysis, which in turn reduces variation and improves the precision of tasks such as cell counting. “Digital pathology is taking off in France. I’m excited to support GHU Paris in their journey as one of the early adopters and proud that Sectra has once again been chosen to help drive the field forward. Ultimately, digitization will bring so many benefits to, for example, cancer patients,” says Fabien Lozach, Managing Director of Sectra in France. Once live with the system, GHU Paris will also be able to increase efficiency during multidisciplinary tumor board meetings (MDTs) since a digital setting makes it possible to display different types of patient data side by side and thereby provide more meaningful discussions. Furthermore, there will no longer be a need to meet physically during MDTs. This is a big advantage for GHU Paris since they are in close contact with pathologists and doctors at other hospitals as part of their participation in RENOCLIP, a national network managing rare tumors of the central nervous system. The contract was signed during the third quarter of Sectra’s 2020/2021 fiscal year. Sectra’s pathology solution is part of its enterprise imaging offering. It provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Read more about Sectra’s enterprise imaging solution and why Sectra PACS has been ranked “Best in KLAS” for seven consecutive years at . About GHU Paris psychiatrie & neurosciences GHU Paris psychiatrie & neurosciences was founded on January 1, 2019, following the merger of three hospitals: Maison Blanche, Perray-Vaucluse and Sainte-Anne. With a total of 60,000 active patients, GHU Paris’s services are used by one in 40 Parisians. GHU Paris’s neuropathology unit is part of the Neuro-St-Anne clinic and collaborates closely with the hospitals affiliated with Paris Descartes University: Cochin, Necker and HEGP. GHU Paris is an expert center in neuroscience and is part of RENOCLIP, a national network specializing in rare tumors of the central nervous system. For more information, visit About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, .
pa|You are here:
di|Menu Mar 22, 2021 |
st|Sectra helps civil authorities and large corporations protect their digital communication with a service that supplements existing products
h2|Images
h3|About Sectra Follow us

/ / Sectra helps civil authorities and large corporations protect their digital communication with a service that supplements existing products Linköping – March 22, 2021 – International cybersecurity and medical imaging IT company (STO: SECT B) is supplementing its offering of secure communication systems with a new service for secure digital communication and remote collaboration. The service will allow Swedish civil authorities and large corporations to communicate more efficiently without jeopardizing the security of their mobile communication between different platforms, such as iPhone, Android, Windows and Mac. The new service will enable voice communication and video conferencing with a high level of security. The servers for the service are located in the same country as the customer and therefore comply with national security requirements and rules regarding data processing and storage. “These days, sensitive information is handled by more people than those involved in national classified communication. We are seeing a growing need among civil authorities and large corporations for a simple, easy-to-use solution for secure communication and collaboration. This new service will provide these authorities and large corporations with a secure solution developed with their needs and day-to-day operations in mind,” says Simo Pykälistö, President of Sectra Communications. The new service comprises an app created by the Swiss and supplied by Sectra, whose authorized employees manage the server and related infrastructure in secure premises in Sweden. The platform supports both mobile and stationary devices and has a modern interface with all of the functions required for efficient digital communication and collaboration, including voice, chat, file transfer and video conferencing functionality. Wire is based on Signal, a well-known, open source security protocol, but is designed for corporations and government authorities, giving them control over their environments and everyone using their systems. By operating the service together with Sectra’s own approved solutions for lower-level encrypted communication, a very high security standard is also achieved for national security solutions. “We’re very proud to partner with Sectra, the leading cybersecurity and medical technology company in the Nordics,” says Morten Brøgger, CEO of Wire. “This partnership is an exciting continuation of our mission to provide enterprises and government organizations with a collaboration solution that protects critical communications and ensures data sovereignty with end-to-end encryption and secure infrastructure.” The service will initially be available in the Swedish market and will be expanded to other markets over time. “We have focused on finding a first-rate, easy-to-use solution for as many platforms as possible. Multi-platform support, including iOS, is something Sectra’s customers are looking for, and this need can now be met,” Simo Pykälistö concludes. About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Sectra thereby contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit . Within the Secure Communications business area, Sectra develops products and services that protect some of society’s most sensitive information and communications. The offering includes secure voice and data communications, with solutions certified at the national level and by the EU and NATO, as well as security analysis and monitoring of critical IT systems, such as electricity and water supply. Sectra’s operations are conducted from its offices in Sweden, the Netherlands, Finland and the USA.
pa|You are here:
di|Menu Mar 12, 2021 | Financial Information | Medical Systems |
h1|Sectra’s nine-month interim report 2020/2021: Increased order bookings and the industry’s most satisfied customers for the eighth consecutive year
h2|Files Images
h3|About Sectra Follow us

/ / Sectra’s nine-month interim report 2020/2021: Increased order bookings and the industry’s most satisfied customers for the eighth consecutive year Press release – Linköping, March 12, 2021 – International medical imaging IT and cybersecurity company (STO: SECT B) has received a top ranking in customer satisfaction surveys in the category of diagnostic imaging systems for radiology in the US, Canada and Europe as well as in the category of digital pathology. As a result of having the market’s most satisfied customers for many years, demand for the company’s offerings is high and order bookings increased 79% compared with the year-earlier period. The third quarter of the preceding fiscal year was extremely strong and the results for this year did not quite reach the same level. The results were hampered by limited delivery opportunities in certain areas of the operations due to the COVID-19 pandemic and by a stronger SEK. Based on unadjusted exchange rates, sales for the nine-month period were on par with the year-earlier period. With tight restrictions still in place in several countries, the heightened risk of delivery delays is expected to continue in the coming quarter. However, Sectra is relatively well equipped to manage the pandemic based on a strong financial position, positive cash flows and a significant share of recurring revenue. Nine-month period, May 2020–January 2021 in figures Order bookings increased 79.1% to SEK 1,962.4 million (1,095.5). Net sales declined 4.1% to SEK 1,106.2 million (1,153.5). Based on unadjusted exchange rates, net sales increased 0.4%. Operating profit rose 8.4% to SEK 186.2 million (171.8), corresponding to an operating margin of 16.8% (14.9). Based on unadjusted exchange rates, operating profit increased 19.5%. Profit before tax amounted to SEK 181.8 million (176.3). The figures include items affecting comparability related to the Secure Communications operating area. These items had a net effect of negative SEK 0.5 million on operating profit. Cash flow after changes in working capital increased to SEK 258.5 million (215.2). Third quarter, November 2020–January 2021 in figures Order bookings increased 38.7% to SEK 598.0 million (431.1). Of the order bookings during the quarter, 17% were recognized as revenue during the quarter and a further estimated 22% to 32% pertains to revenue within 12 months after the end of the quarter. Net sales declined 13.8% to SEK 394.2 million (457.4). Based on unadjusted exchange rates, the decrease was 3.3%. Operating profit declined 30.7% to SEK 69.1 million (99.7), corresponding to an operating margin of 17.5% (21.8). Based on unadjusted exchange rates, operating profit decreased 12.7%. Profit before tax amounted to SEK 67.8 million (100.7). Cash flow after changes in working capital amounted to SEK 136.7 million (134.1). Comments from Torbjörn Kronander, President and CEO of Sectra AB “Satisfied customers are the ultimate proof that our employees and solutions deliver substantial value, which helps to improve the efficiency and quality of healthcare and increase cybersecurity in society. Customer value that in turn creates value for our employees and shareholders. Although the products we offer are highly appreciated, customer satisfaction largely comes down to our employees and how we work together within the company and in consultation with our customers. The foundation for our success in this regard lies in our corporate culture. How we listen to customers to ensure we understand and deliver solutions to their problems, and an entrepreneurial spirit that drives us to achieve innovations that increase customer value. ” “Our earnings and sales did not quite reach the levels reported in the comparative quarter. Given that the third quarter of 2019/2020 was a record-breaking quarter and that we are now burdened by a pandemic and a stronger SEK, we are nevertheless pleased with our results. ” “Even if the pandemic results in a temporary decline in demand in some markets and areas, people will still fall ill and society will still need cybersecurity. With long-term initiatives, investments in existing customer offerings and innovation, we create value for our customers. That way, we help make society healthier and safer.” See the attached interim report for further CEO comments and information. Presentation of the interim report Torbjörn Kronander, President and CEO of Sectra AB, and Mats Franzén, CFO of Sectra AB, will present the financial report and answer questions. The presentation will be held in English. Time: March 12, 2021 10:00 CET Follow live or listen to the recording afterward at To participate by phone, please call one of the following numbers five to ten minutes before the conference begins: SE +46856642706 UK +443333009034 US +18446251570 About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit . Sectra's nine-month interim report 2020/2021
em|This information constitutes information that Sectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and/or the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8:15 a.m. (CET) on March 12, 2021.
pa|You are here:
di|Menu Mar 11, 2021 | Medical Systems | USA​
h1|Sectra signs five-year enterprise imaging contract with Emory Healthcare in the US
h2|Images
h3|About Sectra Follow us

/ / Sectra signs five-year enterprise imaging contract with Emory Healthcare in the US Linköping, Sweden and Shelton, CT – March 11, 2021 – International medical imaging IT and cybersecurity company (STO: SECT B) will install its enterprise imaging solution at Atlanta-based, Emory Healthcare. The contract, signed in February, includes modules for radiology and all imaging subspecialties, orthopedics, and image archiving. Patient linking will be set up with sister institution, Grady Health System, to ensure physicians at both locations have access to shared patient images and reports. The enterprise subscription contract, in addition to the aforementioned products, will include advanced visualization, a zero-footprint viewer, business analytics/real-time dashboard, teaching files, and tumor board capabilities. Emory Healthcare, part of Emory University, is the most comprehensive academic health care system in Georgia. It is made up of 11 hospitals, Emory Clinic, and more than 250 provider locations. The Emory Healthcare Network, established in 2011, is the largest clinically integrated network in Georgia, with more than 2,800 physicians concentrating in 70 different subspecialties. “I am very happy to add Emory Healthcare to our portfolio of prestigious customers. This contract is an example of the flexibility of Sectra’s new licensing model, which is based upon utilization and allows for unlimited growth within the health system. This includes the ability to expand outside of radiology,” says Anthony Grise, Vice President of Sales at Sectra Inc. Sectra’s enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Read more about Sectra and why it’s top-ranked in 'Best in KLAS' at . About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit .
pa|You are here:
di|Menu Mar 10, 2021 |
st|Quantum-proof crypto from Sectra receives SECRET approval from EU
h2|Images
h3|About Sectra Follow us

/ / Quantum-proof crypto from Sectra receives SECRET approval from EU Linköping, Sweden – March 10, 2021 – The EU council has approved the latest version of the eavesdrop-proof mobile phone Sectra Tiger/S 7401 LTE from international cybersecurity and medical imaging IT company (STO: SECT B). This approval, which applies to the security level SECRET, certifies the latest Sectra Tiger/S version for sharing information that, if it fell into the wrong hands, could severely damage the security of the EU and its member nations. Sectra Tiger/S is quantum-proof, and the latest version includes features such as improved file transfer and chat as well as support for all fixed and mobile 4G networks within Europe. These new features provide the user with improved availability, while also enhancing the user experience and areas of application. The voice and file transfer features are approved for use up to and including the security level SECRET UE/EU SECRET. The messaging feature is approved for use up to and including RESTREINT UE/EU RESTRICTED. “A quantum-safe solution is crucial for our customers to keep them secure from any possible attack today or in the future. Given the extensive time horizon of 30-40 years for keeping highly sensitive information and national secrets secure, protection against quantum threats is highly relevant for security solutions that are developed today,” says Simo Pykälistö, President of Sectra Communications. Quantum computers have the capability to perform certain types of calculations much more efficiently than today’s computers. Such computers could thus pose a threat to current encryption methods, and quantum-safe solutions are therefore perceived to be one of the key traits of future-proof confidentiality. About Sectra Tiger/S Sectra Tiger/S is a secure communication solution developed in close cooperation with the Dutch and Swedish security authorities. It allows the user to share classified information up to and including the security level SECRET through encrypted speech, messaging and data transfer. Users include government officials, officials in the diplomatic corps, decision-makers in defense and critical infrastructure, and military personnel in the field. Common to these is that they use security-approved products to communicate securely and that they have high demands on flexibility and mobility. Sectra Tiger/S is part of the Sectra Tiger Ecosystem, along with the smartphone solution Sectra Tiger/R, approved for RESTRICTED-level communication. More than half of the EU member nations use Sectra Tiger solutions to share classified information. This ecosystem approach creates a secure communications environment without crypto islands, allowing the user organization to balance individual security requirements with the right level solution, supporting current and future encryption needs. About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Sectra thereby contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit . Within the business area of Secure Communications, Sectra develops products and services that protect some of society’s most sensitive information and communications. The offering includes secure voice and data communications, with solutions certified at the national level and by the EU and NATO, as well as security analysis and monitoring of critical IT systems, such as electricity and water supply. Sectra’s operations are conducted from its offices in Sweden, the Netherlands, Finland, Norway and the USA.
pa|You are here:
di|Menu Feb 18, 2021 | Financial Information
st|Sectra’s financial reporting calendar and Annual General Meeting Subscribe for information
h1|Invitation to presentation of Sectra’s nine-month interim report on March 12 and date for 2021 Annual General Meeting
h3|About Sectra Follow us

/ / Invitation to presentation of Sectra’s nine-month interim report on March 12 and date for 2021 Annual General Meeting Linköping, Sweden – February 18, 2021 – International medical imaging IT and cybersecurity company (STO: SECT B) will publish its interim report for the May 2020-January 2021 period on March 12. Sectra invites analysts, investors, and the media to attend a teleconference/audiocast in conjunction with the publication of the report. Furthermore, the Board has approved the 2021/2022 financial reporting calendar and has set the date for the company’s Annual General Meeting, which will be held on September 14, 2021, in Linköping, Sweden. Publication of the interim report: 8:15 a.m. (CET) March 12, 2021 Presentation and audiocast: 10:00 a.m. (CET) March 12, 2021 To participate, follow online at or call one of the following numbers five to ten minutes before the conference begins: SE: +46856642706 UK: +443333009034 US: +18446251570 Sectra’s Executive Management will present the interim report and respond to any questions. The presentation will be held in English and a recorded version will be available via after the conference. A PDF version of the presentation will be available for download approximately 30 minutes prior to the event. June 2, 2021, at 8:15 a.m.: Year-end report 2020/2021 September 3, 2021, at 8:15 a.m.: Three-month interim report September 14, 2021, at 3:30 p.m.: Annual General Meeting December 10, 2021 at 8:15 a.m.: Six-month interim report March 9, 2022, at 8:15 a.m.: Nine-month interim report June 3, 2022, at 8:15 a.m.: Year-end report 2021/2022 Further information about Sectra’s financial events and interim reports: To subscribe to financial reports, invitations, and information from Sectra via email, please fill in your contact information at For further information, please contact: Helena Pettersson, Chief Investor Relations Officer Sectra AB, +46 (0)13 23 52 04, e-mail info.investor@sectra.com About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit .
pa|You are here:
di|Menu Feb 9, 2021 |
st|EU orders Sectra Tiger solution for sharing classified information
h2|Images
h3|About Sectra Follow us

/ / EU orders Sectra Tiger solution for sharing classified information Linköping, Sweden – February 9, 2021 – Several EU institutions have procured additional units of the Sectra Tiger mobile encryption system from international cybersecurity and medical imaging IT company (STO: SECT B). The Sectra Tiger system will ensure that users are able to securely and efficiently communicate classified information up to and including the EU SECRET security level, with full availability anywhere and at any time. “We have used the Sectra Tiger system for several years and it meets our high demands for secure communications between Brussels and our EU Delegations around the world. As the pandemic highlighted the need for additional secure exchanges with other EU institutions, the existing Sectra system was naturally considered to cover these new requirements,” says a senior representative from the European External Action Service. The European Union has worked together with Sectra since 2010. Through the procurement of additional units, the EU institutions are extending their use of the Sectra Tiger system, a secure communication solution that allows users to share classified information up to the SECRET security level. Unique features in the Sectra Tiger system allow users to communicate securely between different organizations and security levels, without risking the confidentiality of the information, while ensuring the integrity of each security domain. The orders follow and amounts to approximately SEK 14.5 million. About Sectra Tiger More than half of the EU member states use Sectra Tiger solutions to share classified information. This is possible thanks to the Sectra Tiger Ecosystem, which allows users on different security levels up to and including the SECRET security level to communicate with each other. This ecosystem approach creates a secure communications environment without crypto islands, allowing the user organization to balance individual security requirements with the right level solution, supporting current and future encryption needs. About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Sectra thereby contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit . Within the Secure Communications business area, Sectra develops products and services that protect some of society’s most sensitive information and communications. The offering includes secure voice and data communications, with solutions certified at the national level and by the EU and NATO, as well as security analysis and monitoring of critical IT systems, such as electricity and water supply. Sectra’s operations are conducted from its offices in Sweden, the Netherlands, Finland and the USA.
pa|You are here:
di|Menu Feb 2, 2021 | Medical Systems
st|Sectra ranked #1 in customer satisfaction — earns 5 KLAS awards in PACS and digital pathology Awards won by Sectra:
h2|Images
h3|About Sectra Follow us

/ / Sectra ranked #1 in customer satisfaction — earns 5 KLAS awards in PACS and digital pathology Linköping, Sweden – February 2, 2021 – International medical imaging IT and cybersecurity company (STO: SECT B) has won the prestigious customer satisfaction award ‘Best in KLAS’ for PACS for the eighth consecutive year. Sectra is ranked number one by healthcare providers in three regions: US (Large PACS and Small PACS), Canada, and Europe. The company has also swept the new award for Digital Pathology (non-US). The awards are given by the healthcare IT data and insights company KLAS Research. US customers have, for the eighth year in a row, ranked Sectra’s radiology imaging solution, Sectra PACS, as number one. According to the , the category ‘Culture’ — including the three subjects ‘Keeps all promises’, ‘Product works as promoted’ and ‘Proactive service’ — is where Sectra scores the highest compared to the industry average. “The support people and the people who work with us have all been great. We have had a good relationship with everyone in our local area, the US corporate team, and those who have worked with us from Sweden. Sectra has a good culture. We have seen teams jump in to help, and it seems like everyone works well together,” says a US VP/Other Executive to KLAS Research in December 2020. It is the second year in a row that Sectra has been named ‘Best in KLAS’ for PACS in Canada and Nader Soltani, President of Sectra Canada, comments: “Since we established our Canadian organization three years ago, we have worked intensely to build close relationships with our customers and to provide great support. I am so proud of this seal of quality that proves that our dedication is paying off.” Sectra has its roots in Europe, where it also received the 2021 ‘Best in KLAS’ PACS award. The first installation of the software was in Sweden in 1993 and now, the company has more than 2,000 installations worldwide. Today, the radiology PACS is an integral part of its enterprise imaging solution comprising VNA and spanning all image-intense departments. One of which is the new ‘Best in KLAS’ category Digital Pathology (non-US) that was also won by Sectra. Since the launch of Sectra’s digital pathology solution in 2015, it has grown to support full-scale primary diagnostics at large healthcare providers worldwide to improve cancer diagnostics. During 2020, it also received FDA approval in the US. “Sectra Digital Pathology Solution is a great product. It really suits my needs. When I started using the system, I was really impressed with how well suited the system was for the needs of the pathologist. Sectra is very service minded and easy to get in contact with. When we have suggestions on developmental things or improvements, Sectra is easy to talk to, and they note our suggestions and take them forward. It is really exciting to work with Sectra because we really feel that they listen to us,” says a European Manager to KLAS Research in December 2020. Torbjörn Kronander, President and CEO of Sectra says: “To be selected by our customers as the preferred imaging vendor for digital pathology as well as for radiology across the US, Canada and Europe is a great honor. Happy users are the ultimate proof that Sectra’s staff and solutions deliver great value for our customers, contributing to improving the effectiveness in healthcare.” US Large PACS (300K+ studies) US Small PACS (Under 300K studies) PACS Global (Canada) PACS Global (Europe) Digital Pathology (Non-US) To review Sectra’s KLAS performance data and read comments from its customers, please visit . ECR 2021 To learn more about Sectra and its solutions, join Sectra at ECR. Find out more at . About ‘Best in KLAS’ KLAS has been providing accurate, honest, and impartial insights for the healthcare IT (HIT) industry since 1996. The KLAS mission is to improve the world’s healthcare by amplifying the voice of providers and payers. The scope of our research is constantly expanding to best fit market needs as technology becomes increasingly sophisticated. KLAS finds the hard-to-get HIT data by building strong relationships with our payer and provider friends in the industry. About Sectra With more than 30 years of innovation and approaching 2,000 installations worldwide, Sectra is a leading global provider of imaging IT solutions that support healthcare in achieving patient-centric care. Sectra offers an enterprise imaging solution comprising PACS for imaging-intense departments (radiology, pathology, cardiology, orthopedics), VNA, and share and collaborate solutions. Sectra is leading the way in digital pathology with multiple, fully digital installations throughout the world. Read more about Sectra and why it’s top-ranked in ‘Best in KLAS’ at .
em|2021 Best in KLAS: Software and Services Report
pa|You are here:
di|Menu Published: Jan 28, 2021 | Edited: Jan 29, 2021 | Medical Systems
st|A new consortium of the EU Innovative Medicines Initiative (IMI) will establish the biggest database of pathology images to accelerate the development of artificial intelligence in medicine
h2|Images
h3|About Sectra Follow us

/ / A new consortium of the EU Innovative Medicines Initiative (IMI) will establish the biggest database of pathology images to accelerate the development of artificial intelligence in medicine Nijmegen, 28 January 2021 - To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data. The 6-year, €70 million project called BIGPICTURE, will herald a new era in pathology. Background: Sectra contributes to accelerate AI innovation for diagnostics in digital pathology Sectra engages in the new EU Innovative Medicines Initiative project BIGPICTURE to construct a large-scale database of pathology images. Sectra’s contributions will help accelerate the development of improved diagnostic methods based on artificial intelligence, supporting an effective interplay between healthcare and academic research. The Sectra efforts include a close collaboration with the BIGPICTURE partners Center for Medical Image Science and Visualization (CMIV) at Linköping University and Region Östergötland. The full news: Pathology is the cornerstone of the workup of many diseases such as cancer, autoimmune diseases, of the follow up after transplantation and is also critical for the evaluation of the safety of drugs. It’s based on the examination of tissue samples (slides) under the microscope. However, despite its pivotal role, it still relies heavily on the qualitative interpretation by a qualified pathologist. While the microscope symbolizes the profession, the digitalisation of slides in recent years ignited a revolution: not only can images now be shared and accessed from distant locations, they can also be processed by computers. This opens the door for artificial intelligence (AI) applications to assist the pathologist and help study diseases, find better treatments and contribute to the 3Rs (replace, reduce, and refine animal use in research). However, the development of robust AI applications requires large amounts of data, which in the case of pathology means a huge collection of digital slides and the medical data necessary for their interpretation. Sharing these has so far remained challenging due to the data storage capacity required to host a sufficiently large collection and to concerns regarding the confidential character of the medical information. To allow the fast development of AI in pathology, the BIGPICTURE project aims to create the first European, ethical and GDPR-compliant (General Data Protection Regulation), quality-controlled platform, in which both large-scale data and AI algorithms will coexist. The BIGPICTURE platform will be developed in a sustainable and inclusive way by connecting communities of pathologists, researchers, AI developers, patients, and industry parties. The project is divided into four main aspects that concern the large-scale collection of data. First, an infrastructure (hardware and software) must be created to store, share and process millions of images that can be gigabytes each. Second, legal and ethical constraints must be put in place to ensure adequate usage of data while fully respecting patient’s privacy and data confidentiality. Then, an initial set of 3 million digital slides from humans and laboratory animals will be collected and stored into the repository to provide data for the development of pathology AI tools. Finally, functionalities that aid the use of the database as well as the processing of images for diagnostic and research purposes will be developed. BIGPICTURE is a public-private partnership funded by IMI, with representation from academic institutions, small and medium-sized enterprises (SMEs), public organisations and pharmaceutical companies, together with a large network slide contributing partners. The consortium partners involved in the project are: Academic institutions: Radboud University Medical Center (NL), Linköping University (SE), Leeds Teaching Hospitals NHS Trust (UK), University Medical Centre Utrecht (NL), Uppsala University (SE, ELIXIR node), Haute Ecole Spécialisé de Suisse Occidentale (CH), Eindhoven University of Technology (NL), University of Warwick (UK), Technical University of Munich (DE), Medical University Graz (AT), Institut Pasteur (FR), University of Liege (BE), University of Semmelweis (HU), National Cancer Institute (NL), Region Östergötland (SE), Medical University Vienna (AT), University of Marburg (DE), Helsingin ja Uudenmaan sairaanhoitopiirin kuntayhtymä (FI), Pharmaceutical companies: Novartis Pharma AG (CH), Janssen Pharmaceutica NV (BE), Bayer AG (DE), Boehringer Ingelheim International GmbH (DE), Novo Nordisk A/S (DK), Pfizer Ltd (GB), Roche (CH), Sanofi Aventis recherche et Développement (FR), Institut de Recherches Internationales Servier (FR), and UCB Biopharma SRL (BE). Other public & private organisations: CSC – IT Center for Science Finland (FI, ELIXIR node), Biobanks and biomolecular resources research infrastructure (AT), Azienda Ospedaliera Per L’Emergenza Cannizzaro (IT), Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.(DE), Deutsches Institut für Normung E.V. (DE), European Institute for Innovation through Health Data (BE), European Society of Pathology (BE), Digital pathology association (US), GBG Forschungs Gmbh (DE), ttopstart (NL), Sectra AB (SE), Cytomine SCRLFS (BE), Stichting Lygature (NL), Owkin (FR), Deciphex (IE), MedicalPhit (NL), Timelex (BE). BIGPICTURE starts on 1st February 2021 and will run for 6 years. However, the platform is meant to last, and the consortium will elaborate sustainability plans to maintain and continue to develop the platform beyond this term. Acknowledgement of support and disclaimer This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 945358. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA. This communication reflects the consortium’s view. Neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained therein.
pa|You are here:
di|Menu Jan 21, 2021 | Medical Systems | The Netherlands
h1|Amsterdam UMC adds digital pathology to its existing Sectra solution to enable integrated diagnostics for better cancer care
h2|Images
h3|About Sectra Follow us

/ / Amsterdam UMC adds digital pathology to its existing Sectra solution to enable integrated diagnostics for better cancer care Linköping, Sweden – January 21, 2021 – International medical imaging IT and cybersecurity company (STO: SECT B) has received an order for its digital pathology solution from Amsterdam UMC in the Netherlands. This follows a recently announced . With radiology and pathology in one joint solution, Amsterdam UMC will be able to conveniently share images and information between the two medical specialties, enabling efficient integrated diagnostics and improved patient-centric care. “It’s exciting to see how Amsterdam UMC, in just a short time, has taken these steps toward radiology and pathology efficiency, regional collaboration and integrated diagnostics. I’m confident that our experience and vendor-neutral platform will contribute to their adoption of emerging technologies, such as AI, in the future,” says Peter Osinga, Managing Director of Sectra Benelux. One of the main benefits of digitizing pathology is the ability to share digital images, rather than sending physical slides back and forth. This helps healthcare providers reduce treatment errors as well as logistics and administration, resulting in potential savings. Access to specialists for efficient external readings and second opinions can also cut waiting times for patients—helping pathology to meet patient demand and regulatory enforcements. Sectra’s digital pathology solution will be integrated with the laboratory information system (LIS) used at Amsterdam UMC. This will provide pathologists with a complete overview of the patient history in one application and enable workflow orchestration to drive the workflow according to sub-specialties, rules and priorities. The solution’s vendor-neutral approach also enables Amsterdam UMC to use the scanner vendor of its choice. The contract was signed during the third quarter of Sectra’s fiscal year 2020/2021. Sectra’s pathology solution is part of its enterprise imaging offering, which provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular enterprise imaging solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Read more about Sectra’s enterprise imaging solution and why Sectra PACS is ranked “Best in KLAS” for seven consecutive years at medical.sectra.com . About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit .
pa|You are here:
di|Menu Jan 19, 2021 | Medical Systems | France
st|Institut Bergonié among the first in France to implement full-scale digital pathology—improves care for cancer patients with solution from Sectra
h2|Images
h3|About Sectra Follow us

/ / Institut Bergonié among the first in France to implement full-scale digital pathology—improves care for cancer patients with solution from Sectra Linköping, Sweden – January 19, 2021 – International medical imaging IT and cybersecurity company (STO: SECT B) has received an order from Institut Bergonié for its digital pathology solution. It will be one of the first digital pathology installations for full-scale primary diagnostics in France. The solution will enable pathologists to review and collaborate around cases in a manner previously not possible using a microscope. It reduces variation and increases efficiency, thereby improving care for cancer patients. “We have been looking for an intuitive solution that will allow our pathologists to quickly adapt and utilize all the benefits that come with the technology. It was also important to find a vendor with solid experience of similar installations. Sectra ticked all the boxes,” says Dr. Gaëtan MacGrogan, Chief Pathologist at Institut Bergonié. The Institut Bergonié is a non-profit private hospital and offers dedicated inpatient and outpatient cancer treatment. It is part of UNICANCER, which is a national hospital network of 20 French Comprehensive Cancer Centres. “Institut Bergonié is at the forefront of fighting cancer. It is now taking yet another important step as one of the first hospitals in France to adopt a digital pathology workflow. We are really looking forward to working together to help Institut Bergonié reach its vision for cancer care,” says Fabien Lozach, Managing Director of Sectra France. The solution will be integrated with the laboratory information system (LIS) at Institut Bergonié. Tight integration between Sectra’s solution and the LIS will provide pathologists with a complete overview of patient history—in one application—and enable an efficient workflow based on, for example, sub-specialization and priority. The solution’s vendor-neutral approach also provides freedom of choice in selecting a scanner vendor. The five-year contract was signed in December 2020. Sectra’s digital pathology solution Sectra’s digital pathology solution includes digital tools that enable pathologists to make their diagnoses and carry out reporting with higher precision and less time spent per case. Using digital images of tissue samples rather than physical glass slides, pathologists can access and share current and historical images and information from anywhere and at any time. Digital access also facilitates second opinions, external reading resources and specialist consultations, in addition to enabling integrated diagnostics. It is a complete, vendor-neutral solution for primary diagnostics that includes storage solutions and an advanced review workstation. Sectra’s pathology solution is part of its enterprise imaging solution. It provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Read more about Sectra’s enterprise imaging solution and why Sectra PACS is ranked “Best in KLAS” for seven consecutive years at . About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit .
pa|You are here:
di|Menu Jan 14, 2021 | Medical Systems | Denmark
h2|Images
h3|About Sectra Follow us

/ / Healthcare region pioneering digital pathology reviews in Denmark with Sectra—aims to significantly shorten cancer turn-around times Healthcare region pioneering digital pathology reviews in Denmark with Sectra—aims to significantly shorten cancer turn-around times Linköping, Sweden – January 14, 2021 – The healthcare provider Region of Southern Denmark has gone live with a digital pathology solution from international medical imaging IT and cybersecurity company (STO: SECT B). The IT solution makes it possible for pathologists at the region’s four hospitals to review and collaborate around cases in a way that is not possible with microscopes. This supports increased efficiency in primary diagnostics, thereby improving cancer care. “Despite disruptions caused by the COVID-19 pandemic, the project has been carried out according to schedule and budget, and I am proud of and impressed by the outstanding collaboration that made this possible. For the Region of Southern Denmark to move to full-scale digital pathology is a milestone for cancer care in Denmark as it is key to meeting the ambitions for shorter lead times set by the national cancer care pathways,” says Sune Henriksen, President, Sectra Denmark. The Region of Southern Denmark is the first Danish healthcare region to digitize pathology in full scale. With Sectra’s digital pathology solution, resource utilization and sub-specialization can be optimized at the region’s four geographically dispersed hospitals. This enables the region to provide all patients with equal access to healthcare services, regardless of their location. The go-live follows the . Digitizing pathology brings pathologists new functionality beyond the microscope. Without the need for physical glass slides, digital access enables them to instantly access and share current and historical images and information between departments and hospitals as well as the possibility to benefit from evolving technology such as AI. The digital solution provides pathologists with assistance at critical decision points, such as grading or performing more precise measurements. It also enables image analysis, which in turn reduces variation and improves the precision of tasks such as cell counting. Digital access further facilitates second opinions, external reading resources, and specialist consultations. Sectra’s pathology solution is part of its enterprise imaging offering, which provides a unified strategy for all imaging needs, and improves patient outcomes while lowering operational costs. The scalable and modular solution supports the most image-intense departments—radiology, breast imaging, pathology, cardiology and orthopaedics. Because the offering is built on the same technical platform, customers can easily extend a departmental solution to create a comprehensive VNA. Read more about Sectra’s enterprise imaging solution and why Sectra PACS is “Best in KLAS” at . About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit .
pa|You are here:
di|Menu Jan 11, 2021 | Medical Systems
st|Rapid go-live as first trust in Greater Manchester patient diagnostic imaging initiative deploys Sectra solution
h2|Images
h3|About Sectra Follow us

/ / Rapid go-live as first trust in Greater Manchester patient diagnostic imaging initiative deploys Sectra solution Linköping, Sweden – January 11, 2021 – The Pennine Acute Hospitals NHS Trust has become the first of eight NHS trusts in the UK to deploy the imaging IT solution from international medical imaging IT and cybersecurity company (STO: SECT B). This follows the . The go-live is transforming how clinical staff examine crucial patient images. Faster diagnoses for millions of people, new possibilities around AI, and region-wide collaboration are just some of the benefits that will follow. Elaine Quick, Greater Manchester’s PACS implementation lead, said: “I am really impressed with how teams across the trust have worked with our partner Sectra to get this in place quickly whilst simultaneously dealing with the challenges presented by Covid-19 and winter pressures in the NHS. This first go-live is the start of the main journey. We will be able to maximize how our staff work across different trusts and we will be able to connect 15 years’ worth of rich data currently isolated in individual trusts.” A new region-wide approach to analyzing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images has started to become reality, now that The Pennine Acute has become the first of eight trusts across Greater Manchester to deploy state-of-the-art medical imaging technology. Healthcare professionals at the trust have begun using a new enterprise imaging solution to benefit patients only weeks after the Greater Manchester Provider Federation Board signed a landmark contract with Sectra in October 2020. The agreement represents one of the largest imaging initiatives of its kind in the NHS and anywhere in Europe. This news at Pennine Acute is regarded as the first step in an initiative that will transform the way patients are diagnosed and treated. The imaging solution (PACS) is used by hospital staff to review patient images digitally. It replaces ageing IT and is already delivering immediate benefits to staff such as being able to view and report on detailed images remotely, including from their homes. In the case of surgical scenarios, 3D orthopaedic tools will allow staff to virtually reconstruct joints prior to procedures. And the system is expected to transform how multidisciplinary teams function. The biggest wins from the initiative are expected as an accelerated delivery program expands the new PACS and an accompanying multimedia system known as a vendor neutral archive (VNA), both supplied by Sectra, across Greater Manchester. Once the solution is live and rolled out in more hospitals, clinical staff will be able to instantly access patient images captured at any of the participating NHS trusts in the region. This will support healthcare professionals making decisions at the point of care and help staff carrying out reports used to inform diagnoses. The program paves the way for better and faster access to scarce expertise and faster diagnoses for 3.2 million people across Greater Manchester at a time of national staff recruitment challenges in specialist disciplines like radiology. David O’Brien, divisional managing director for imaging, said: “This is an important project for everyone – from frontline staff, through to patients whose care this is ultimately about. Hospitals in Greater Manchester will overcome interorganizational limitations around image sharing and collaboration. Radiology demand has increased massively in recent years and continues to do so. Working as a network will help us to respond to this demand and ensure our professionals’ expertise is available for everyone in the region. In the future, the program will allow us to embrace new and emerging tools like artificial intelligence, and in the short term it is allowing radiologists to continue working from home at a crucial time.” Suraj Amonkar, consultant radiologist and PACS clinical lead for Pennine, said: “Radiology is pivotal in patient care management. Sectra provides us with a powerful, thoroughly up-to-date PACS system that has many advanced features that will result in quicker and more accurate diagnostics, and ultimately better patient care. The integrated multidisciplinary team meeting (MDT) module will benefit oncology patients, whilst the teaching features will help train the next generation of radiologists, radiographers and sonographers. It works well with our existing digital patient record systems, and with a zero footprint viewer is easily accessible to clinicians delivering frontline care. We look forward to exploring its huge potential.” The Pennine Acute consists of hospitals in Oldham, Bury, Rochdale and North Manchester. The Oldham, Bury and Rochdale sites are managed along with Salford Royal NHS Foundation Trust as the Northern Care Alliance. The North Manchester site is managed as part of the Manchester University NHS Foundation Trust Group. Other hospitals that will benefit as deployment continues at pace over the next year include: Bolton NHS Foundation Trust The Christie NHS Foundation Trust Manchester University NHS Foundation Trust Salford Royal NHS Foundation Trust (part of the Northern Care Alliance NHS Group) Stockport NHS Foundation Trust Tameside and Glossop Integrated Care NHS Foundation Trust Wrightington, Wigan and Leigh NHS Foundation Trust Jane Rendall, managing director UK and Ireland at Sectra, said: “Greater Manchester is delivering fast on its determination to get modern tools and crucial information to the people that need them. Diagnostic imaging is a crucial part of patient care. For the millions of people covered by this new program, the first steps have been taken in an initiative that will transform the way they are diagnosed and treated.” About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributesThe company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit .